Interim Report September 1, 2018 - May 31, 2019
Company Announcement No 08, 2019
Solid sales growth and profitability in Q3, but reduced organic growth outlook for the year.
Attachment
Upcoming Life Sciences Events
- April 2024
- London: BioTrinity 2024
- Singapore: Asia Bio Partnering Forum
- London: LSX World Congress
Latest company news
TVM Capital Healthcare Announces US$ 17 Million Investment into neurocare